Akermin

Biotechnology ResearchMissouri, United States11-50 Employees

Akermin is developing a novel solution to efficiently remove carbon dioxide (CO2) from industrial gas streams using biocatalysis and nanotechnology. The Company uses a multi-disciplined approach to integrate enzymes within proprietary delivery systems that can be readily incorporated into conventional processes for CO2 removal using chemical absorption. Akermin’s Biocatalyst Delivery System enables the enzyme to work efficiently and for an extended period of time addressing the key issue of enzyme stability in harsh industrial environments. Akermin’s environmentally-friendly approach to CO2 removal significantly reduces capital and operating costs thus creating a strong value proposition for the customer. Initial commercial sales are expected in 2015 using a license and consumables business model with established industrial partners. Akermin is targeting commercial launches for biogas upgrading and LNG liquefaction; two market segments that are experiencing strong growth with limited options for cost-effective, reliable “green” solutions for CO2 removal. Future efforts will expand to other sizable markets including hydrogen and ammonia production, oil sands boilers, and power generation.

Sign up for free to view info

Email Format Employee directory